Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B Clinical research trials and Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B. Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B clinical trial. Subjects often receive the most expert healthcare possible for their Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.

Home > "E" Clinical Trials Conditions > Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B

Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B



Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B

For Condition: Chronic Hepatitis B
Status: No longer recruiting
Sponsor(s): Hoffmann-La Roche ,
Synopsis: The purpose of this study is to determine the safety and efficacy of Pegasys + placebo + lamivudine versus lamivudine alone in patients with lamivudine versus lamivudine alone in patients with hepatitis B antigen CHB.
Details:
Eligibility:
Study Type:
  Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Clinical diagnosis of hepatitis B - Not pregnant Exclusion Criteria: - Treatment for hepatitis B in past 6 months - Other hepatitis infections - Severe liver disease - Pregnancy
Total Enrollment: 

Location and Contact Information:


Additional Information:
Study ID Numbers:
  WV16240; 
Study Start Date: 
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00048945

Other Chronic Hepatitis B Studies:
1. Safety and antiviral study of ACH-126, 443 (beta-L-Fd4C) in the treatment of adults with chronic Hepatitis B infection.

2. A Phase III Study of Entecavir vs Lamivudine in Chronic Hepatitis B Subjects with Incomplete Response to Lamivudine

3. Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

4. A Phase III Study of Entecavir vs Lamivudine in Adults with Chronic Hepatitis B Infection and negative for Hepatitis B e Antigen

5. Safety and antiviral study of ACH126, 433 (b-L-Fd4C) in adults with lamivudine-resistant chronic hepatitis B

Related Studies:

Other Chronic Hepatitis B Clinical Trials
Other Clinical Trials
Other HANGZHOU Clinical Trials

Efficacy and safety study of Pegasys in the treatment of chronic hepatitis B

Modify your Search

  Other Chronic Hepatitis B Clinical Trials
  Other Clinical Trials
  Other HANGZHOU Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103